AbCellera Biologics (ABCL) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.14
-0.07
0.01
0.08

Details

Expected EPS
-0.13
Actual EPS
-0.11
Surprise EPS
0.02
Surprise Percent
+15.38%

Description

AbCellera Biologics (ABCL) has reported earnings of -0.11 per share for Q2 2023.

0 Comments

Share your thoughts